Scarica l'app Stockscreener
3.03
3.81%
-0.12
Dopo l'orario di chiusura:
3.09
0.06
+1.98%
Stereotaxis Inc Borsa (STXS) Ultime notizie
Order flow analysis tools used on Stereotaxis Inc.Weekly Stock Report & Free High Return Stock Watch Alerts - newser.com
Stereotaxis Synchrony System Gets European CE Mark; Applies for FDA 510(k) Certification - Diagnostic and Interventional Cardiology
Is Stereotaxis Inc. stock trading near support levelsMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com
Will Stereotaxis Inc. stock outperform tech sector in 2025Exit Point & Momentum Based Trading Ideas - newser.com
Can Stereotaxis Inc. stock continue upward trendMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Stereotaxis Earns EU Nod for Synchrony System, Submits to FDA - Medical Product Outsourcing
How Stereotaxis Inc. stock stacks up against competitors2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Stereotaxis teams with CardioFocus to develop robotic PFA system - MedTech Dive
Stereotaxis Obtains CE Mark in Europe, Files Application to FDA for Synchrony System - MarketScreener
Stereotaxis (STXS) Moves Forward with Synchrony System Approvals - GuruFocus
Stereotaxis obtains CE mark for Synchrony system, files FDA application By Investing.com - Investing.com Canada
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs - GlobeNewswire
CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud - Stock Titan
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation - sharewise.com
Stereotaxis, CardioFocus Collab to Advance Robotic Pulsed Field Ablation - Medical Product Outsourcing
Stereotaxis (STXS) Partners with CardioFocus to Develop Robotic PFA Technology - GuruFocus
Stereotaxis and CardioFocus partner to develop robotic PFA technology - Investing.com
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewswire
Is Stereotaxis Inc. stock trading at attractive multiplesWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Stereotaxis Inc Stock Analysis and ForecastInstitutional Holding Changes & Free Explosive Portfolio Gains - earlytimes.in
Can Stereotaxis Inc. stock resist broad market declinesJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Stereotaxis, Inc. Hits New 52-Week High of $3.58, Marking Key Milestone - Markets Mojo
Is Stereotaxis Inc. stock attractive for income investorsRate Cut & Expert Curated Trade Setup Alerts - newser.com
Stereotaxis, Inc. Hits New 52-Week High at USD 3.37 - Markets Mojo
Stereotaxis, Inc. Hits New 52-Week High at $3.33 - Markets Mojo
Stereotaxis Inc. stock daily chart insightsPortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
Can you recover from losses in Stereotaxis Inc.Earnings Risk Summary & Weekly Return Optimization Plans - newser.com
Is Stereotaxis Inc. stock ready for breakoutWeekly Stock Summary & Expert Verified Movement Alerts - newser.com
Key resistance and support levels for Stereotaxis Inc.M&A Rumor & Long-Term Safe Investment Ideas - newser.com
What market sentiment indicators show for Stereotaxis Inc. stockJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Tools to assess Stereotaxis Inc.’s risk profileJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Stereotaxis, Inc. Hits New 52-Week High at USD 3.20 - Markets Mojo
5.05%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):